Navigation Links
Men Might Get Their Share of Cervical Cancer Vaccine As Well

The first ever-cervical cancer vaccine, Gardasil is expected to be launched in New Zealand soon, targeting females between 9 and 24 years of age. // Soon, men might also be given cervical cancer vaccines to prevent them from infecting their sexual partners and to protect themselves against several diseases.

The vaccine is currently under experimental phase, for demonstration of cervical cancer prevention. Most cases of cervical cancer can be attributed to human papilloma virus infection (HPV), spread through sexual contact. An association between the virus and anal cancer has also been observed, consistent with high reports of infection among gay men.

Previous vaccine trials had demonstrated the increase in antibody production against the four target HPV types, known to cause cancer and genital warts in both men and women. There could be a 70% reduction in the cervical cancer incidence if the vaccine is found to be effective in preventing HPV associated cervical cancers.

It has been found form numerous studies that 80% of the population is exposed to HPV at some point during their lifetime. A majority of this goes unnoticed, as there are no symptoms. The immune system may be effective in getting rid of the virus. A small group of people however develop persistent infections.

The effectiveness of the vaccine would be more relevant when it is administered before onset of sexual activity. Taking this fact into account, the ideal age for administration of the vaccine is considered to be 11 years. If approved for use, it can be incorporated as the last of injections on the national immunization schedule.

Cervical cancer represents a major health care burden haunting women. This may be the focus for increased clinical trials in women when compared to the poor attention given to prevention of HPV-linked cancers in men. However, large clinical trials involving men are being conducted, the results of which would
'"/>




Page: 1 2

Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Men Might Get Their Share Cervical Cancer Vaccine Well

(Date:4/22/2014)... percent of all lung cancers are small cell ... develop resistance to chemotherapy. However, researchers at Virginia ... insights into the mechanisms leading to this resistance ... Chemotherapies work primarily by mediating B-cell lymphoma 2 ... cell death. Depending on their function, this family ...
(Date:4/22/2014)... 2014Hemoglobin A1c is the standard measurement for assessing glycemic ... of A1c are typically measured every few months in ... model that accurately estimates A1c using self-monitored blood glucose ... Therapeutics ( DTT ), a peer-reviewed journal from ... free on the DTT website at ...
(Date:4/22/2014)... PHILADELPHIA (April 22, 2014) That person we all seem ... take action? Turns out he or she isn,t unable to ... A study of nearly ... about why neurotic people may avoid making decisions and moving ... if action is positive, favorable, good, they just don,t like ...
(Date:4/22/2014)... -- In parallel with modern man ( Homo sapiens ), ... we lived side by side, such as Neanderthals and the ... sapiens survived. What was it in our genetic makeup ... little is known about our unique genetic makeup as distinguished ... fact that we are the only species among them ,to ...
(Date:4/22/2014)... Disease (IBD), a group of chronic inflammatory disorders of ... affects over 1.4 million people in the U.S., and ... there is no cure. , Now, Cincinnati Cancer ... Susan Waltz, PhD, and scientists in her lab have ... genetic study to document the important function for the ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Neurotics don't just avoid action: They dislike it 2Health News:What gave us the advantage over extinct types of humans? 2Health News:Two genes linked to inflammatory bowel disease 2
... and predicting the tumours that will metastasize in lymph nodes ... 3rd International Conference on innovative approaches in Head and Neck ... Radboud University Nijmegen Medical Centre, the Netherlands, reported results of ... The study was jointly led by scientists from Nijmegen and ...
... Michigan State University has secured a $7.9 million ... Mozambique through increasing the African nation,s agricultural productivity, ... four-year grant, funded by the U.S. Agency for ... University of Florida. The initiative employs trilateral cooperation, ...
... of the factors reported by those who say they are unhappy ... its kind, published in the launch issue of the new online ... challenge the perception that these patients can no longer enjoy quality ... the authors. The research team quizzed 168 members of the ...
... four new grants to help improve awareness, prevention and ... in China and India. The grants total nearly $1 ... hepatitis-related health disparities in Asia to $8 million USD ... announced at the Asian Pacific Association for the Study ...
... 24 (HealthDay News) -- An analysis of proteins in spinal ... with chronic fatigue syndrome, a new study reports. It ... involve the central nervous system and that protein abnormalities in ... conditions, said the research team, which was led by Dr. ...
... suffer from delirium each year, however the condition goes ... if diagnosed, there is no effective way to treat ... professionals. Researchers, clinicians, and administrators from across ... - 7 for "Advancing Delirium Care through Research," the ...
Cached Medicine News:Health News:Gene expression to distinguish metastasizing from non-metastasizing head and neck cancers 2Health News:$7.9 million grant to improve food security, nutrition in Mozambique 2Health News:Most 'locked-in syndrome' patients say they are happy 2Health News:Bristol-Myers Squibb Foundation awards nearly $1M to HBV, HCV awareness, prevention and care 2Health News:Bristol-Myers Squibb Foundation awards nearly $1M to HBV, HCV awareness, prevention and care 3Health News:Spinal Fluid May Hold Clues to Lyme Disease, Chronic Fatigue Syndrome 2Health News:Advancing delirium care through research 2
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Inquire...
Rapid Urease test for the presumptive identification of H. pylori in gastric mucosal biopsies...
... The QuickVue H.pylori gII test is a ... qualitative detection of IgG antibodies specific to ... whole blood. It utilizes a convenient, non-invasive, ... aid physicians in the diagnosis of H.pylori ...
... a visually read, qualitative immunochromatographic method for ... a bacterium that grows in the stomach ... and some gastric cancers. FlexSure HP, available ... serum samples, provides the physician with the ...
Medicine Products: